Boston Scientific
1,222 hedge funds and large institutions have $90.8B invested in Boston Scientific in 2024 Q1 according to their latest regulatory filings, with 155 funds opening new positions, 443 increasing their positions, 451 reducing their positions, and 69 closing their positions.
125% more first-time investments, than exits
New positions opened: 155 | Existing positions closed: 69
16% more capital invested
Capital invested by funds: $78.3B → $90.8B (+$12.4B)
6% more funds holding
Funds holding: 1,148 → 1,222 (+74)
0% more funds holding in top 10
Funds holding in top 10: 27 → 27 (0)
2% less repeat investments, than reductions
Existing positions increased: 443 | Existing positions reduced: 451
3% less call options, than puts
Call options by funds: $468M | Put options by funds: $482M
2.1% less ownership
Funds ownership: 92.48% → 90.38% (-2.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$910M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$424M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$237M |
| 4 |
JP Morgan Chase
New York
|
+$183M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$172M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.26B |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$680M |
| 3 |
Newport Trust Company
Washington,
District of Columbia
|
-$390M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$203M |
| 5 |
Amundi
Paris,
France
|
-$168M |
BSX Hedge Fund Activity: Q1 2024 in Review
1,222 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2024, worth a combined $90.8B — up 16% from $78.3B a quarter earlier.
Buyers outnumbered sellers: 155 funds opened new BSX positions and 69 closed out — a net gain of 86 holders — while 443 added to existing stakes and 451 trimmed.
The largest buyer was Franklin Resources, adding an estimated $910M. The largest seller was Morgan Stanley, cutting an estimated $1.26B.
- 1,222 institutional investors held Boston Scientific (BSX) as of Q1 2024, up from 1,148 in Q4 2023.
- Funds reported $90.8B of Boston Scientific stock for Q1 2024, up 16% quarter-over-quarter.
- 155 funds opened new Boston Scientific positions in Q1 2024 and 69 closed out, a net change of +86 holders.
- The largest Boston Scientific buyer in Q1 2024 was Franklin Resources, an estimated $910M added.
- The largest Boston Scientific seller in Q1 2024 was Morgan Stanley, an estimated $1.26B sold.
Based on aggregated 13F filings for Q1 2024.